Dainippon Sumitomo, Others Back Vaccine For TB Injectable
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma and two other investors plan to spend $8.3 million to take shares of Create Vaccine, a Japan-based developer of tuberculosis vaccine injections, according to sources.